Comparison of the effects on glycaemic control and β‐cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel‐group trial (the <scp>CONFIDENCE</scp> study)
Wen Xu(Sun Yat-sen University), Jianping Weng(University of Science and Technology of China), Lixin Guo(Peking University), J. Lu(Chinese PLA General Hospital), Shujia Li(Qingzhou City People's Hospital), Lihong Shi(Weifang Medical University), Xuefeng Yu(National Clinical Research Center for Digestive Diseases), Yan Bi(Nanjing Drum Tower Hospital), Xiaoyi Lv(Fujian Medical University), Qiuhe Ji(Xijing Hospital), Linong Ji(Peking University), Zerong Liang(Red Cross Hospital), H. Li(Kunming Medical University), Zhongyan Shan(First Hospital of China Medical University), Shuo Lin(Shantou University), Jinhua Yan(Sun Yat-sen University), Longyi Zeng(Sun Yat-sen University), Wenying Yang(China-Japan Friendship Hospital), Q. Li(Harbin Medical University), Zhiguang Zhou(Central South University), Xiaohui Guo(Peking University), Zilin Sun(Zhongda Hospital Southeast University), Li Yan(Sun Yat-sen University), Tao Yang(Jiangsu Province Hospital), Jingjia Li(Sun Yat-sen University), Guifu Wu(Sun Yat-sen University), Lei Qiu(Inner Mongolia Medical University), Zuojie Luo(First Affiliated Hospital of GuangXi Medical University)
Cited by 59
Related Papers
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
|Pharmacological Reviews|2021|1.1k
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations
|Diabetes Care|2016|969
Standards of care for type 2 diabetes in China
|Diabetes/Metabolism Research and Reviews|2016|321